Prior to VPA/hydralazine treatment, DNMT3a, DNMT1 (Fig. 6b) or HDAC1 (Fig. 6c) expression was not different in the mammary tumors of HF offspring, compared with controls. The gene discussed is HDAC1; the disease is breast cancer.